Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Cell Transfection System

August 26, 2010 9:42 am | Product Releases | Comments

Lonza’s 4D-Nucleofector System is lifting the Amaxa Nucleofector Technology to the next dimension. Lonza engineers and scientists have developed a system which is designed for maximum flexibility combined with advanced performance and convenience.


Scientists Develop Atomic View of Key Genetic Processes

August 26, 2010 9:36 am | News | Comments

Using X-ray crystallography, Penn State researchers have built the first-ever image of a protein interacting with the nucleosome—DNA packed tightly into space-saving bundles organized around a protein core. The research is expected to aid future investigations into diseases such as cancer.


Researchers Find New Mechanism for Making Memories

August 26, 2010 9:32 am | News | Comments

Scientists have discovered a mechanism that plays a critical role in the formation of long-term memory. The findings shed substantial new light on aspects of how memory is formed, and could lead to novel treatments for memory disorders.


Frog Skin May Destroy Antibiotic-Resistant Germs

August 26, 2010 9:22 am | News | Comments

Kissing a frog won’t turn it into a prince — except in fairy tales ? but frogs may be hopping toward a real-world transformation into princely allies in humanity’s battle with antibiotic-resistant infections that threaten millions of people worldwide.


More Problems At J & J Subsidiary

August 26, 2010 9:18 am | News | Comments

Johnson & Johnson's artificial joint business is recalling two hip replacement products, just two days after getting hit with a government warning that it is illegally marketing two other products. It is the 11th J&J recall since September.


IDBS Acquires Quantrix

August 26, 2010 7:24 am | News | Comments

IDBS, a worldwide provider of data management and analytics solutions to healthcare organizations, announced that it has concluded an agreement to acquire Quantrix, a company that provides business modeling and analytics software and services.


Judge Blocks Sanofi Injunction Request

August 26, 2010 7:20 am | News | Comments

Momenta Pharmaceuticals, Inc. announced that a judge has denied sanofi-aventis' request for a preliminary injunction directing the FDA to suspend and withdraw its approval of the ANDA filed by Momenta's partner, Sandoz, for a generic version of Lovenox.


PROLOR Cleared for Phase 2 Trial

August 26, 2010 7:14 am | News | Comments

PROLOR Biotech, Inc. announced that it has received regulatory clearance from the U.S. Food and Drug Administration to conduct a Phase 2 clinical trial in the U.S. of its longer-acting version of human growth hormone, hGH-CTP.


Daiichi Sankyo Files for Denosumab Approval

August 26, 2010 7:09 am | News | Comments

Daiichi Sankyo Company, Limited, announced that it has filed for approval in Japan to manufacture and market AMG 162 (denosumab), a gene recombinant drug for bone disorders stemming from bone metastases.


FDA Approves Protocol for Phase 2 Trial

August 26, 2010 7:01 am | News | Comments

Chelsea Therapeutics International, Ltd. announced confirmation that the U.S. Food and Drug Administration has approved its proposed Phase 2 protocol for CH-4051 in rheumatoid arthritis. Patient screening is to begin next month and treatment starts in October.


Afferent Drug Reduces Bladder Hyperactivity

August 26, 2010 6:55 am | News | Comments

Afferent Pharmaceuticals, a biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, announced results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.


Edge And SurModics Collaborate on TBI Treatment

August 26, 2010 6:43 am | News | Comments

According to the agreement, SurModics will develop Edge Therapeutics' lead candidate, Nimogel, a novel biodegradable, site-specific, sustained-release formulation for treatment of delayed complications of ruptured brain aneurysms or traumatic brain injury.


Hybrid Multi-Mode Microplate Reader

August 25, 2010 8:35 am | Product Releases | Comments

BioTek, a market leader in hybrid microplate detection technology, has released its newest product, the Synergy H1 Hybrid Multi-Mode Microplate Reader.


UV-Visible Spectrophotometer

August 25, 2010 8:31 am | Product Releases | Comments

Thermo Fisher Scientific Inc. announced the launch of its Evolution 200 series of next-generation UV-Visible spectrophotometers featuring new INSIGHT software with CUE (Customized User Environment) scripting capabilities.


Sanger And Horizon Collaborate On Translational Genomics

August 25, 2010 8:21 am | News | Comments

Two Cambridge-based organisations, the Wellcome Trust’s Sanger Institute and Horizon Discovery, will collaborate to translate the abundance of new information on human genetic variation into more effective treatments for cancer.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.